Tra i malati di cancro, l'incidenza di problemi cardiovascolari è maggiore rispetto a quella nella popolazione non colpita da patologie tumorali: i motivi possono essere molteplici (probabilmente un ruolo non di secondaria rilevanza lo rivestono gli effetti collaterali di chemio e radioterapia), ma sicuramente il monitoraggio ed un occhio specificamente più attento possono aumentare l'indice di sopravvivenza.
Questo articolo spinge a valutare con attenzione il rapporto rischio/benefici di qualsiasi terapia, ivi compresa la chemioterapia: anche per questo motivo diventa essenziale la ricerca di terapie avanzate innovative, e quella immunologica va in questa direzione.
King Hamad Univerity Hospital Lecture
William G. Kaelin, MD, of Harvard University, Boston, Massachusetts, Gregg L. Semenza, MD, PhD, of Johns Hopkins University in Baltimore, Maryland, and Sir Peter J. Ratcliffe, FMedSci, of Oxford University in the United Kingdom have been awarded the 2019 Nobel Prize in Physiology or Medicine.
These mechanisms of cell adaptation to the presence or lack of Oxygen may also have important implications in the tumour field. For example, alterations in the vascularity of a solid tumor could damage part of the cells to the point of death, but also stimulate the survivors to grow adapting to the new deficiency condition. As always happens, there are systems of counterweights and counter-reactions constantly in action in the living, new balances are formed. Finding ways to intervene with drugs and substances to achieve a therapeutic aim remains a challenge.
Cryoablation may be associated with longer overall survival than heat-based thermal ablation in clinical T1a renal cell carcinoma (RCC), concludes a recent study published in the Journal of Vascular Interventional Radiology. To date, this is the largest study comparing overall survival between two ablative therapies in these patients.
In our centers in the Santa Elena Clinic in Malaga and Hippocrates DOO Nova Gorica and for the patients who come to Trieste in Via Fabio Severo 3, these criteria have been implemented for years. In fact, the simple prostatic examination combined with PSA transrectal ultrasound and biparametric MRI have been in use for many years. We have established a wonderful collaboration with prestigious international university and research centers that guarantee us the highest possible accuracy through the use of up-to-date 3 Tesla nuclear magnetic resonance technologies of the latest generation
Prostate cancer in TZ in a large prostate: cryosurgery with bilateral preservation of nerves for total preservation of erections. Continence preserved. A couple of needles are inseryed also in the other side adenoma to improve urinary flow.
This interesting case offer the opportunity to treat with target ablation two problems: urinary disuria caused by Prostate enlargement and cancer in a single step while preserving potency and continence. Great work with Santa Elena team in Malaga Spain
This important article deals with the consequences of vasectomy.
Vasectomy is widely used to avoid pregnancies and is performed with a small outpatient procedure to bind sperm ducts.
The article is surprising for two reasons:
First of all, it seems to show that those who undergo vasectomy have 15% more diagnosed with prostate cancer, with an increased risk after 10 years.
The second observation is that vasectomics are generally healthier than the rest of the population.
So we can ask:
The subjects who undergo vasectomy are those who have a more active sex life because they are healthier?
Are vasectomy subjects healthier because they have more sex?
Do non-vasectomized subjects who are healthier have more sex?
Do non-vasectomized subjects who have more sex have a higher risk of prostate cancer?
Are vasectomized and non-vasectomized subjects healthier because they have more sex or vice versa?
Doctor Lugnani visiting Professor to University Hospital Dieu de France Beyruth e University Hospital Rayak.
Images are also taken from Malaga International Cryoteam
Screening decisions can be more complex than treatment decisions, well-designed decision-making aid could help patients understand the risks and benefits
Patients should be able to participate in health decisions, decision-making aids have been developed to help patients make informed decisions on treatment and to improve knowledge if they so wish and for these reasons.
However, in screening, where informed choice is not a common practice, decision-making aids are controversial and their effect is currently unknown.
A Finnish team analyzed 19 randomised controlled studies that compared DA’s for prostate cancer screening with the usual therapy. They found out the DA’s are:
- Probably associated with the improvement of knowledge (evidence of low quality).
- Probably associated with a small decrease in decision conflict (evidence of moderate quality).
- Probably not associated with doctors and patients discussing prostate cancer screening (low quality evidence) or with men’s decision to undergo prostate cancer screening (low quality test).
Note that randomised and controlled studies of prostate cancer screening das compared to usual treatments are heterogeneous in DA content, design, delivery and results.
Looking to the future, it should include the possibility of continuous updating of new evidence and not only provide education for patients, but also promote a shared decision-making process in the doctor-patient meeting.
Conversations , conferences , lectures, interviews . In Italian , English and Castilian language . Various topics: prostate cancer prevention, cryosurgery laser, cryosurgery, advanced therapies etc.